Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002095969-25-000002
Filing Date
2025-11-20
Accepted
2025-11-20 12:34:19
Documents
1
Effectiveness Date
2025-11-20
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 17238
  Complete submission text file 0002095969-25-000002.txt   18542
Mailing Address 345 PARK AVENUE NEW YORK NY 10154
Business Address 345 PARK AVENUE NEW YORK NY 10154 212-583-5000
Blackstone Life Sciences VI - BL L.P. (Filer) CIK: 0002095969 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-564548 | Film No.: 251502039